ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
iShares Genomics Immunology and Healthcare ETF
40.79
-0.7700
-1.85%
盘后:
40.80
0.0100
+0.02%
19:38 EDT
成交量:
10.86万
成交额:
445.39万
市值:
3.10亿
市盈率:
- -
高:
41.35
开:
41.24
低:
40.77
收:
41.56
52周最高:
43.44
52周最低:
23.90
股本:
760.00万
流通股本:
760.00万
量比:
0.77
换手率:
1.43%
股息:
0.28
股息率:
0.69%
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻资讯
福泰制药(VRTX)股票10月13日盘中下跌3.13%:投资者必看的核心信息
TradingKey中文
·
14小时前
Intellia Therapeutics 任命 Jing L. Marantz 医学博士为首席医疗官
投资观察
·
昨天
Syndax:肺病药物中期试验未达主要目标,终止研发
路透中文
·
昨天
Moderna Inc(MRNA)股票10月12日盘中下跌5.73%:背后推手曝光
TradingKey中文
·
昨天
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/IDNA"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":40.79,"timestamp":1791921600000,"preClose":41.56,"halted":0,"volume":108628,"hourTrading":{"tag":"盘后","latestPrice":40.8,"preClose":40.79,"latestTime":"19:38 EDT","volume":2619,"amount":106792.18,"timestamp":1791934739061,"change":0.01,"changeRate":0.000245,"amplitude":0.001961},"delay":0,"changeRate":-0.018527430221366773,"floatShares":7600000,"shares":7600000,"eps":0,"marketStatus":"未开盘","change":-0.77,"latestTime":"10-13 16:00:00 EDT","open":41.24,"high":41.35,"low":40.77,"amount":4453909.638464,"amplitude":0.013956,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791964800000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":41.56,"sharesOutstanding":5100000,"nav":41.457933,"aum":315080290.8,"dividendRate":0.006913,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":41.65,"preClose":41.56,"latestTime":"04:00 EDT","volume":75,"amount":3123.75,"timestamp":1791878401691,"change":0.09,"changeRate":0.002166,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":40.8,"preClose":40.79,"latestTime":"19:38 EDT","volume":2619,"amount":106792.18,"timestamp":1791934739061,"change":0.01,"changeRate":0.000245,"amplitude":0.001961},"volumeRatio":0.770685,"impliedVol":0.3284,"impliedVolPercentile":0.8685},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":7600000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.770685,"shares":7600000,"dividePrice":0.282,"high":41.35,"amplitude":0.013956,"preClose":41.56,"low":40.77,"week52Low":23.9,"pbRate":"--","week52High":43.44,"institutionHeld":0,"latestPrice":40.79,"eps":0,"divideRate":0.006913,"volume":108628,"delay":0,"ttmEps":0,"open":41.24,"prevYearClose":26.19,"prevWeekClose":42.17,"prevMonthClose":42.32,"prevQuarterClose":42.32,"fiveDayClose":40.87,"twentyDayClose":38.5885,"sixtyDayClose":32.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2675136687","title":"福泰制药(VRTX)股票10月13日盘中下跌3.13%:投资者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2675136687","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675136687?lang=zh_cn&edition=fundamental","pubTime":"2026-10-14 00:15","pubTimestamp":1791908152,"startTime":"0","endTime":"0","summary":"• 受生物科技板块走弱与技术性卖压影响,福泰制药面临股价下行压力。\n• 囊性纤维化领域的领先地位及管线多元化持续支撑其核心基本面。\n• 技术指标显示 MACD 卖出信号和威廉指标(Williams %R)超卖状态。","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262214484-market-movers-vrtx-20261013","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","BK4585","BIB","SG9999001176.USD","LU1674673428.USD","IE0002270589.USD","IE00B2B36J28.USD","BK4139","IE00B19Z3B42.SGD","LU2089984988.USD","LU2468319806.SGD","LU0058720904.USD","LU0320765992.SGD","LU0256863811.USD","IDNA","IBB","LU0823416689.USD","LU0889565916.HKD","SG9999013999.USD","GNMX","LU1069344957.HKD","IBBQ","LU0234570918.USD","VRTX","TBXU","LU2324357040.USD","BK4567","LU0417517546.SGD","BK4533","LU2237438978.USD","LU2362541513.USD","LU0079474960.USD","BBH","LU1093756325.SGD","SGXZ57979304.SGD","IE00B894F039.SGD","IE00BJJMRZ35.SGD","LU0109394709.USD","LU2236285917.USD","LU2417539215.USD","IE00B19Z9P08.USD","LU1035775433.USD","LU2362540622.SGD","LU1430594728.SGD","LU1585245621.USD","IE00BFTCPJ56.SGD","PBE","LU1093756168.USD","IE0009355771.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148923252","title":"Intellia Therapeutics 任命 Jing L. Marantz 医学博士为首席医疗官","url":"https://stock-news.laohu8.com/highlight/detail?id=1148923252","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148923252?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 19:33","pubTimestamp":1791891213,"startTime":"0","endTime":"0","summary":"马萨诸塞州剑桥,2026年10月13日——专注于利用CRISPR基因编辑及其他核心技术革新医学的领先生物制药公司Intellia Therapeutics, Inc.今日宣布,任命Jing L. Marantz医学博士、哲学博士为执行副总裁兼首席医疗官,自2026年10月26日起生效。Marantz博士是一位成就卓著的药物开发领军人物,在生物制药行业拥有逾25年经验,曾成功推动多款现已获批的罕见病疗法向前迈进。履新后,她将全面领导公司的转化研究、开发、监管及医学事务职能。她是Arcturus Therapeutics, Inc.董事会成员。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","R","IDNA","BK4232","BK4585","LU1861559042.SGD","BK4535","LU1861558580.USD","BK4556","NTLA","BK4139","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675009908","title":"Syndax:肺病药物中期试验未达主要目标,终止研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2675009908","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675009908?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 04:39","pubTimestamp":1791837557,"startTime":"0","endTime":"0","summary":"Syndax:肺病药物中期试验未达主要目标,终止研发路透10月12日-Syndax Pharmaceuticals周一表示,由于一项中期临床试验未能达到主要目标,该公司将停止开发一种用于治疗特发性肺纤维化的药物。该药物已在美国获批用于治疗该病症。Syndax表示,该中期研究未能实现其主要目标,即与安慰剂相比降低肺功能年下降率。据Syndax称,该疗法耐受性良好,安全性特征与安慰剂相当,且未发现新的安全性问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nL4S45Y19I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","SNDX","BK4550","INCY","BK4588","IDNA","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675802022","title":"Moderna Inc(MRNA)股票10月12日盘中下跌5.73%:背后推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2675802022","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675802022?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 03:15","pubTimestamp":1791832557,"startTime":"0","endTime":"0","summary":"• 莫德纳股价走低,主因投资者在近期上涨后获利了结。\n• 华尔街分析师指出,由于公司尚未盈利且现金消耗居高不下,其面临估值阻力。\n• 该公司报告年营收为19.4亿美元,并录得净亏损。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262212369-market-movers-mrna-20261012","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4588","WDNA","BK4534","BK4585","BK4532","BK4548","LGHT","BK4139","GNOM","IDNA","MRNX","MRNY","BK4501","BK4533","BK4568","MRNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IDNA\",params:#limit:6,delay:false,,,undefined,":[]}}